BIO International Convention, June 22–25, 2026
PackGene Biotech is pleased to attend the BIO International Convention 2026, one of the world’s leading gatherings for the biotechnology and life sciences industries. The event brings together global leaders from biotech, pharma, academia, investment, and service sectors to advance innovation, build partnerships, and explore new opportunities across the therapeutic development landscape.
At this year’s convention, PackGene will showcase its integrated solutions for genetic medicine development, including high-performance AAV production, lentiviral vector manufacturing, mRNA/LNP services, and plasmid DNA production. Our platforms are designed to support programs from early discovery and preclinical research through IND-enabling studies and GMP manufacturing.
Dr. Xin Swanson, Chief Strategy Officer, and the PackGene team look forward to meeting with researchers, cell and gene therapy developers, and industry partners to discuss how our end-to-end capabilities can help accelerate therapeutic innovation from bench to bedside.
To schedule a meeting with PackGene during BIO 2026, please connect with us through the BIO Partnering™ System or visit us at Booth 5821.
Details
Date: June 22–25, 2026
Venue: San Diego Convention Center, San Diego, CA
Booth: 5821
Contact: Dr. Xin Swanson, Chief Strategy Officer, info@packgene.com
Related Download
Related Service
-
AAV Production Services
- Fast, high-quality AAV vectors with reliably low empty capsid content
- 70+ serotypes, 40+ QC assays, and precision vector design expertise
- 50,000+ AAV batches delivered; effortless transition to GMP manufacturing
-
Custom mRNA Service
- High-quality mRNA with full QC panel
- Custom scales, stability, and modifications
- End-to-end support from design to manufacturing
-
Custom mRNA-LNP Service
- Increased stability with protected mRNA delivery
- Enhanced uptake via optimized LNP formulations
- Reduced immunogenicity for safer applications
-
GMP AAV Manufacturing
- High-productivity GMP AAV manufacturing with a scalable production platform.
- Cost-effective solutions featuring in-house GMP plasmid manufacturing and comprehensive release testing.
- Rapid timeline to GMP AAV production and clinical application, backed by a strong record of successful delivery.
- Proven track record of supporting over 40 IIT (Investigator-Initiated Clinical Trial) programs.
-
GMP Plasmid
- cGMP plasmid production up to 200L, with flexible scaling for any project size.
- Strict contamination control by isolated production lines and advanced single-use technology.
- 10+ years of expert plasmid manufacturing, with comprehensive process and technical support.
-
Plasmid Preparation
- Flexible sizes from 100µg to 2g (preclinical) and up to 100g (GMP)
- Sequence fidelity ensured with customizable QC testing
- Fast delivery for all drug development stages
